Cargando…
Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes
PURPOSE: Immune checkpoint inhibitor (ICI) monotherapy and combination regimens are being actively pursued as strategies to improve durable response rates in cancer patients. However, the biology surrounding combination therapies is not well understood and may increase the likelihood of immune-media...
Autores principales: | Goggi, J. L., Tan, Y. X., Hartimath, S. V., Jieu, B., Hwang, Y. Y., Jiang, L., Boominathan, R., Cheng, P., Yuen, T. Y., Chin, H. X., Tang, J. R., Larbi, A., Chacko, A. M., Renia, L., Johannes, C., Robins, Edward G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497445/ https://www.ncbi.nlm.nih.gov/pubmed/32705455 http://dx.doi.org/10.1007/s11307-020-01519-3 |
Ejemplares similares
-
Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer
por: Goggi, Julian L, et al.
Publicado: (2021) -
Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma
por: Goggi, Julian L., et al.
Publicado: (2021) -
Granzyme B PET Imaging in Response to In Situ Vaccine Therapy Combined with αPD1 in a Murine Colon Cancer Model
por: Hartimath, Siddesh V., et al.
Publicado: (2022) -
An Improved Synthesis of N-(4-[(18)F]Fluorobenzoyl)-Interleukin-2 for the Preclinical PET Imaging of Tumour-Infiltrating T-cells in CT26 and MC38 Colon Cancer Models
por: Khanapur, Shivashankar, et al.
Publicado: (2021) -
Imaging Effector Memory T-Cells Predicts Response to PD1-Chemotherapy Combinations in Colon Cancer
por: Goggi, Julian L., et al.
Publicado: (2022)